[{"_1":2,"_88":-5,"_89":-5},"loaderData",{"_3":4,"_26":27},"root",{"_5":6,"_17":10,"_18":19,"_20":21,"_22":10,"_23":-5,"_24":-5,"_25":10},"user",{"_7":8,"_9":10,"_11":10,"_12":-5,"_13":-5,"_14":15,"_16":-5},"roles",[],"isAuthenticated",false,"isPremium","planName","subscriptionStatus","featureFlags",{},"insightsBudget","isDevelopmentHost","userPreferences",{},"recaptchaSiteKey","6LcvOJcUAAAAAHsB-gPGfGktcRlKpH7OTIU_dMTD","isImpersonating","impersonation","affiliateStatus","isFreedomPortal","routes/v2/article/layout",{"_28":29,"_30":31},"notFound",true,"relatedArticles",[32,76],{"_33":34,"_35":36,"_37":38,"_39":40,"_41":42,"_43":44,"_45":46,"_47":48,"_49":50,"_51":52,"_53":54,"_55":56,"_57":58,"_59":60,"_61":62,"_63":64,"_65":66,"_67":68,"_69":70,"_71":72,"_73":74,"_75":74},"mediaId",6361943,"mediaKeyId","2169188-977ad60c4bedc2f376c198d66a1db1ef","parentId",2169188,"title","Senate committee amends bill to create screening process for recreationally sold substances; questions raised on scope and costs","audioSeconds",524,"startMs",74000,"endMs",598000,"viewUrl","/Search/View?dp=1&key=2169188-977ad60c4bedc2f376c198d66a1db1ef&start=74&end=598","thumbnailUrl","https://assets.pipeline.soar.com/2169188-977ad60c4bedc2f376c198d66a1db1ef/thumbnail_74000.jpg","articleUrl","/articles/6361943/Mississippi/Senate-committee-amends-bill-to-create-screening-process-for-recreationally-sold-substances-questions-raised-on-scope-and-costs","mediaUrl","https://secure.pipeline.soar.com/6361943-d727d0a33d03a308ad726f8ec61f9012/orig.mp4?Expires=1771194602&Signature=cfMvUAiCHnCe0I8BADcHswLnkOstIvU78yz19Z1TTmCe0782ao3fRPwQYjWR7ozKKU-Hx~TB3EIe7QXpVWUjDho-wOpIx1cVpC23TdJpqSImHWZUznIU74KU~P0R5fue4cFFIpyZK9S0DRPLGYRr1FKhiws7uBib6Y0ID~N0B3d7HEqXFDWmE~clb7xCz6p3daFf0f5ElXP2oQB3ifJQg~pB1PONck4QUMH673NFd9cglcDmfWFq-AmCfaRSVfPJw1u1UfDWwiB0TIKSmUz079fvXilgE98iEkH2KfkphvlocwEDm6d6DPTV2OmyzGNy3JHypVAO~9B6wnUxKDkcfw__&Key-Pair-Id=KUT5TJCACFTXG","author","Mississippi Legislature","date","2025-01-30T00:00:00Z","article","A Senate committee on Wednesday amended and reported Senate Bill 2354, a bill that would create a screening program for recreationally used or abused substances sold in retail outlets, and referred it out of committee after lawmakers added a reverse-repealer amendment and discussed implementation concerns.

The committee chair said the bill was recommended by medical providers and aims to screen certain products being sold in convenience stores and similar retailers. The chair noted some of these products have been linked to adverse reactions and that local law enforcement has expressed concern about their availability.

Senators questioned what products would be covered. One senator asked whether hemp products would be included; the chair responded that hemp was “not necessarily” included and described the bill as applying to substances used at a recreational level and associated with abuse. Another senator said the purpose section (Section 2b) names some over-the-counter items but cautioned that the Department of Health may not have the capacity to run a program of the bill’s magnitude without dedicated funding.

Senator Sparks criticized overly broad coverage, saying he did not want the health department “deciding how big my Coca Cola is because that's not good for me either,” and added that he does not think people should “shop for your medicine at the convenience store.” Another senator, citing law enforcement, said testing suspected retail products is expensive for local labs and that those products are a major current concern, especially for youth.

Committee members discussed adding implementation details, including whether the Department of Health could collect fees for testing or applications and whether delayed implementation would allow rulemaking before program start. The committee approved an amendment to add a reverse repealer; a senator moved the amendment, members approved it by voice vote, and the chair said the bill would be considered amended. Later the committee moved that the bill title was sufficient and approved sending the bill out of committee.

The transcript records discussion about scope, testing costs, and administrative capacity but does not include a roll-call vote or any agency estimate of testing fees. The bill was amended in committee and reported out for further legislative consideration.","mediaType","Video","parentTitle","Drug Policy - Room 409, 30 January, 2025; 8:30 A.M.","oneSentenceSummary","A Senate committee amended and reported Senate Bill 2354 to establish a screening program for recreationally used or abused products sold at retail; members sought clarity on scope, testing fees and implementation, and the committee added a reverse repealer amendment.","taxTitle","Drug Policy, Senate, Committees, Legislative, Mississippi","taxId",30847,"location","Mississippi","headline","","shortSummary",{"_33":77,"_35":36,"_37":38,"_39":78,"_41":79,"_43":80,"_45":81,"_47":82,"_49":83,"_51":84,"_53":85,"_55":56,"_57":58,"_59":86,"_61":62,"_63":64,"_65":87,"_67":68,"_69":70,"_71":72,"_73":74,"_75":74},6361948,"Senate committee advances bill updating Schedule I to mirror federal listings",73,0,73000,"/Search/View?dp=1&key=2169188-977ad60c4bedc2f376c198d66a1db1ef&start=0&end=73","https://assets.pipeline.soar.com/2169188-977ad60c4bedc2f376c198d66a1db1ef/thumbnail_0.jpg","/articles/6361948/Mississippi/Senate-committee-advances-bill-updating-Schedule-I-to-mirror-federal-listings","https://secure.pipeline.soar.com/6361948-086cf37dd7422baf142c268f0806953f/orig.mp4?Expires=1771194602&Signature=XM6taBk3-dPNOhNRa1XZR9aYd5qlxUEW0lV6hhs2HBNqPpuznI3pjFEi3-QJ5KZamiFmyidNHGpqiVPhh9k5aaoxQkXMDMXTJeQ3CqPTmZxEETNON1axmReFLahHpJR6GIvvd5cGb0QqSgoj5z~0LvLQK8zg2rmjP2wJwgsmYPfyzHmxwD-yR6MaOjYo5RWUtw2etLhsywlAwV~nuei42qId~I0ar6B2VchMS8~SVSkO7F~J2dceRuHypjvAkfg5K7npoM7h~AzkBq2wlevLrFeMGAML5LyaaUG9kiHn-tnFD46NMpwQBZLOELwEisroYykQprWFeJQWMQTpHJfGEg__&Key-Pair-Id=KUT5TJCACFTXG","A Senate committee on Wednesday voted to advance Senate Bill 2356, a measure to revise the state's Schedule I under the Uncontrolled Substances Act to conform with recent federal regulatory changes, the committee chair said.

The bill was brought at the recommendation of the State Board of Health, which reviews federal regulatory changes each year and advises the Legislature on aligning state schedules, the chair said. Dr. Edney of the health department was present for the item but did not make substantive remarks during the committee record.

Committee members noted the bill adds roughly nine fentanyl derivatives, along with three opioids and a small number of other substances, to Schedule I. After no questions were raised, an unnamed senator moved that the bill's title was sufficient and that it should “do pass.” Committee members responded “aye” and the chair said the bill would be removed from the committee calendar.

The action advances the state Schedule I changes recommended by the State Board of Health; the bill text and implementing rules will determine how the listed substances are handled in practice. The hearing record included no formal objections from the State Board of Health and no detailed discussion of penalties or enforcement tied specifically to this bill.

The committee did not record a roll-call vote in the transcript excerpt; the motion on the title was approved by voice vote and the chair indicated the bill was removed from the committee agenda.","A Senate committee voted to advance Senate Bill 2356, which updates the state's Schedule I of the Uncontrolled Substances Act following recommendations from the State Board of Health; Dr. Edney attended but offered no extended remarks.","actionData","errors"]

Article not found

Senate committee amends bill to create screening process for recreationally sold substances; questions raised on scope and costs

Senate committee advances bill updating Schedule I to mirror federal listings